Dysfunctional mitochondrial fission impairs cell reprogramming.

Data de publicació:

Autors de IIS La Fe

Autors aliens a IIS La Fe

  • Barneo-Muñoz M
  • Torres J

Grups d'Investigació

Abstract

We have recently shown that mitochondrial fission is induced early in reprogramming in a Drp1-dependent manner; however, the identity of the factors controlling Drp1 recruitment to mitochondria was unexplored. To investigate this, we used a panel of RNAi targeting factors involved in the regulation of mitochondrial dynamics and we observed that MiD51, Gdap1 and, to a lesser extent, Mff were found to play key roles in this process. Cells derived from Gdap1-null mice were used to further explore the role of this factor in cell reprogramming. Microarray data revealed a prominent down-regulation of cell cycle pathways in Gdap1-null cells early in reprogramming and cell cycle profiling uncovered a G2/M growth arrest in Gdap1-null cells undergoing reprogramming. High-Content analysis showed that this growth arrest was DNA damage-independent. We propose that lack of efficient mitochondrial fission impairs cell reprogramming by interfering with cell cycle progression in a DNA damage-independent manner.

Dades de la publicació

ISSN/ISSNe:
1538-4101, 1551-4005

Cell cycle (Georgetown, Tex.)  Landes Bioscience

Tipus:
Article
Pàgines:
3240-3250
PubMed:
27753531
Factor d'Impacte:
1,723 SCImago
Quartil:
Q1 SCImago

Cites Rebudes en Web of Science: 33

Documents

  • No hi ha documents

Mètriques

Filiacions mostrar / ocultar

Keywords

  • Gdap1; cell reprogramming; iPS cells; mitochondrial fission; pluripotency

Projectes associats

DEVELOPMENT OF A HIGH THROUGHPUT GENOMICS-BASED TEST FOR ASSESSING GENOTOXIC AND CARCINOGENIC PROPERTIES OF CHEMICAL COMPOUNDS IN VITRO

Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL

CARCINOGENOMICS . COMISION EUROPEA . 2006

TRANSDIFERENCIACIÓN DE FIBROBLASTOS A HEPATOCITOS MEDIANTE REPROGRAMACIÓN CELULAR

Investigador Principal: BERNARDO ROQUE BORT MARTÍ

SAF2010-15376 . MINISTERIO DE CIENCIA E INNOVACION . 2010

INNOVALIV: INNOVATIVE STRATEGIES TO GENERATE HUMAN HEPATOCYTES FOR TREATMENT OF METABOLIC LIVER DISEASES: TOOLS FOR PERSONALIZED CELL THERAPY

Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL

278152_INNOVALIV_PE_CASTELL_FP7-HEALTH-2011-two-st . COMISION EUROPEA . 2011

INDUCCION DE LA ACTIVIDAD MYC POR LA HOMEOPROTEINA HHEX: ASPECTOS BASICOS Y APLICACIONES A FENOMENOS ONCOLOGICOS Y DE REPROGRAMACION

SAF2011-29718 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2012

NUEVA ESTRATEGIA PARA LA DERIVACIÓN DE HEPATOCITOS FUNCIONALES DE MUJERES AFECTAS DE DEFICIENCIA DE ORNITINA TRANSCARBAMILASA

Investigador Principal: BERNARDO ROQUE BORT MARTÍ

SAF2014-51991-R . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2015

AYUDAS PARA CONTRATOS PREDOCTORALES PARA LA FORMACION DE DOCTORES ASOCIADO AL SAF2014-51991-R

Investigador Principal: BERNARDO ROQUE BORT MARTÍ

BES-2015-075387 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2016

EUTOXRISK21. AN INTEGRATED EUROPEAN ‘FLAGSHIP’ PROGRAM DRIVING MECHANISM-BASED.

Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL

681002_EUTOXRISK_CASTELL_H2020-PHC-33-2015 . COMISION EUROPEA . 2016

Compartir la publicació